1.
Grundy SM: Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008, 28(4):629-636.
2.
van Vliet-Ostaptchouk JV, Nuotio M-L, Slagter SN, Doiron D, Fischer K, Foco L, Gaye
A, Gögele M, Heier M, Hiekkalinna T: The prevalence of metabolic syndrome and metabolically healthy obesity in Europe:
a collaborative analysis of ten large cohort studies. BMC Endocr Disord 2014, 14(1):9.
3.
Browning JD, Szczepaniak LS, Dobbins R, Horton JD, Cohen JC, Grundy SM, Hobbs HH:
Prevalence of hepatic steatosis in an urban population in the United States: impact
of ethnicity. Hepatology 2004, 40(6):1387-1395.
4.
Grundy SM: Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 2007, 92(2):399-404.
5.
Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K, Fruchart J, James W,
Loria C, Smith Jr S: International Diabetes Federation Task Force on Epidemiology and Prevention; National
Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation;
International Atherosclerosis Society; International Association for the Study of
Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International
Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung,
and Blood Institute; American Heart Association; World Heart Federation; International
Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120(16):1640-1645.
6.
Cameron AJ, Shaw JE, Zimmet PZ: The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004, 33(2):351-375.
7.
Holick MF: Vitamin D: the underappreciated D-lightful hormone that is important for skeletal
and cellular health. Curr Opin Endocrinol Diabetes Obes 2002, 9(1):87-98.
8.
Rostand SG: Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 1997, 30(2):150-156.
9.
Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P: Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes & Control 2000, 11(9):847-852.
10.
Grant WB: An estimate of premature cancer mortality in the US due to inadequate doses of solar
ultraviolet‐B radiation. Cancer 2002, 94(6):1867-1875.
11.
Apperly FL: The relation of solar radiation to cancer mortality in North America. Cancer Res 1941, 1(3):191-195.
12.
Nagpal S, Na S, Rathnachalam R: Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005, 26(5):662-687.
13.
Caron‐Jobin M, Morisset AS, Tremblay A, Huot C, Légaré D, Tchernof A: Elevated serum 25 (OH) D concentrations, vitamin D, and calcium intakes are associated
with reduced adipocyte size in women. Obesity 2011, 19(7):1335-1341.
14.
Scragg R, Sowers M, Bell C: Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health
and Nutrition Examination Survey. Am J Hypertension 2007, 20(7):713-719.
15.
Smotkin-Tangorra M, Purushothaman R, Gupta A, Nejati G, Anhalt H, Ten S: Prevalence of vitamin D insufficiency in obese children and adolescents. J Pediatr Endocrinol Metab 2007, 20(7):817-824.
16.
Scragg R, Sowers M, Bell C: Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and
Nutrition Examination Survey. Diabetes care 2004, 27(12):2813-2818.
17.
Lu L, Yu Z, Pan A, Hu FB, Franco OH, Li H, Li X, Yang X, Chen Y, Lin X: Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged
and elderly Chinese individuals. Diabetes care 2009, 32(7):1278-1283.
18.
Ford ES, Ajani UA, McGuire LC, Liu S: Concentrations of serum vitamin D and the metabolic syndrome among US adults. Diabetes care 2005, 28(5):1228-1230.
19.
Hyppönen E, Boucher BJ, Berry DJ, Power C: 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age A cross-sectional
study in the 1958 British Birth Cohort. Diabetes 2008, 57(2):298-305.
20.
Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, McCabe EL, Robins SJ, O'Donnell
CJ, Hoffmann U, Jacques PF: Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes 2010, 59(1):242-248.
21.
Reis JP, von Mühlen D, Kritz-Silverstein D, Wingard DL, Barrett-Connor E: Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in
community-dwelling older adults. Diabetes care 2007, 30(6):1549-1555.
22.
Bonakdaran S, Varasteh A-R: Correlation between serum 25 hydroxy vitamin D3 and laboratory risk markers of cardiovascular
diseases in type 2 diabetic patients. Saudi Med J 2009, 30(4):509-514.
23.
Rueda S, Fernández-Fernández C, Romero F, de Osaba MJM, Vidal J: Vitamin D, PTH, and the metabolic syndrome in severely obese subjects. Obes Surg 2008, 18(2):151-154.
24.
Liu E, Meigs JB, Pittas AG, McKeown NM, Economos CD, Booth SL, Jacques PF: Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype
in nondiabetic adults. J Nutr 2009, 139(2):329-334.
25.
Tai K, Need AG, Horowitz M, Chapman IM: Glucose tolerance and vitamin D: effects of treating vitamin D deficiency. Nutrition 2008, 24(10):950-956.
26.
Mahmood SF, Idiculla J, Joshi R, Joshi S, Kulkarni S: Vitamin D supplementation in adults with vitamin D deficiency and its effect on metabolic
syndrome–a randomized controlled study. Int J Vitam Nutr Res 2018, 86.
27.
Ju SY, Jeong HS, Kim DH: Blood Vitamin D Status and Metabolic Syndrome in the General Adult Population: A Dose-Response
Meta-Analysis. J Clin Endocrinol Metab 2013, 99(3):1053-1063.
28.
Amirbaigloo A, Hosseinpanah F, Sarvghadi F, Tohidi M, Eskandary PS, Azizi F: Absence of Association Between Vitamin D Deficiency and Incident Metabolic Syndrome:
Tehran Lipid and Glucose Study. Metab Syndr Relat Disord 2013, 11(4):236-242.
29.
Sarrafzadegan N, Talaei M, Sadeghi M, Kelishadi R, Oveisgharan S, Mohammadifard N,
Sajjadieh AR, Kabiri P, Marshall T, Thomas GN: The Isfahan cohort study: Rationale, methods and main findings. J Hum Hypertens 2010, 25(9):545-553.
30.
World Health Organization: Obesity: preventing and managing the global epidemic: World Health Organization, Geneva 2000.
31.
McNamara JR, Schaefer EJ: Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chem Acta 1987, 166(1):1-8.
32.
Warnick G, Nguyen T, Albers A: Comparison of improved precipitation methods for quantification of high-density lipoprotein
cholesterol. Clin Chem 1985, 31(2):217-222.
33.
Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D’Agostino
RB, Wolf M, Vasan RS: Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117(4):503-511.
34.
Hollis BW: Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs. Am J Clin Nutr 2008, 88(2):507S-510S.
35.
Mohammadifard N, Kelishadi R, Safavi M, Sarrafzadegan N, Sajadi F, Sadri GH, Maghroon
M, Alikhasi H, Heydari S, Sarmadi F: Effect of a community-based intervention on nutritional behaviour in a developing
country setting: the Isfahan Healthy Heart Programme. In: Public Health Nutr. vol. 12; 2009: 1422-1430.
36.
Khosravi-Boroujeni H, Ahmed F, Sadeghi M, Roohafza H, Talaei M, Dianatkhah M, Pourmogaddas
A, Sarrafzadegan N: Does the impact of metabolic syndrome on cardiovascular events vary by using different
definitions? BMC public health 2015, 15(1):1.
37.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss
RM, Savage PJ, Smith SC: Diagnosis and management of the metabolic syndrome an American Heart Association/National
Heart, Lung, and Blood Institute scientific statement. Circulation 2005, 112(17):2735-2752.
38.
Food and Nutrition Board. Institute of Medicine: Dietary reference intakes for calcium and vitamin D: National Academies Press; 2011.
39.
Need AG, O'Loughlin PD, Morris HA, Coates PS, Horowitz M, Nordin B: Vitamin D metabolites and calcium absorption in severe vitamin D deficiency. J Bone Miner Res 2008, 23(11):1859-1863.
40.
Organization WH: Prevention and management of osteoporosis: report of a WHO scientific group: Diamond Pocket Books (P) Ltd.; 2003.
41.
Holick MF: Vitamin D deficiency. N Engl J Med 2007, 357(3):266-281.
42.
Raposo L, Martins S, Ferreira D, Guimarães JT, Santos AC: Vitamin D, parathyroid hormone and metabolic syndrome–the PORMETS study. BMC Endocr Disord 2017, 17(1):71.
43.
Li L-H, Yin X-Y, Yao C-Y, Zhu X-C, Wu X-H: Serum 25-hydroxyvitamin D, parathyroid hormone, and their association with metabolic
syndrome in Chinese. Endocrine 2013, 44(2):465-472.
44.
Kayaniyil S, Harris S, Retnakaran R, Vieth R, Knight J, Gerstein H, Perkins B, Zinman
B, Hanley A: Prospective association of 25 (OH) D with metabolic syndrome. Clin Endocrinol 2014, 80(4):502.
45.
Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ, Sikaris K, Ebeling PR,
Daly RM: Low serum 25-hydroxyvitamin D is associated with increased risk of the development
of the metabolic syndrome at five years: results from a national, population-based
prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). J Clin Endocrinol Metab 2012, 97(6):1953-1961.
46.
Forouhi NG, Luan Ja, Cooper A, Boucher BJ, Wareham NJ: Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin
resistance the medical research council ely prospective study 1990–2000. Diabetes 2008, 57(10):2619-2625.
47.
Autier P, Boniol M, Pizot C, Mullie P: Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2014, 2(1):76-89.
48.
Glendenning P, Chew G: Controversies and consensus regarding vitamin D deficiency in 2015: whom to test and
whom to treat? Med J Aust 2015, 202(9):470-471.
49.
Pilz S, Verheyen N, Grübler MR, Tomaschitz A, März W: Vitamin D and cardiovascular disease prevention. Nat Rev Cardiol 2016.
50.
Yu C, Xue H, Wang L, Chen Q, Chen X, Zhang Y, Hu G, Ling W: Serum bioavailable and free 25-hydroxyvitamin D levels, but not its total level, are
associated with the risk of mortality in patients with coronary artery disease. Circulation Research 2018, 123:CIRCRESAHA. 118.313558.
51.
Sauer CG, Loop MS, Venkateswaran S, Tangpricha V, Ziegler TR, Dhawan A, McCall C,
Bonkowski E, Mack DR, Boyle B: Free and Bioavailable 25-Hydroxyvitamin D Concentrations are Associated With Disease
Activity in Pediatric Patients With Newly Diagnosed Treatment Naïve Ulcerative Colitis. Inflamm Bowel Dis 2018, 24(3):641-650.
52.
Vitezova A, Zillikens M, van Herpt T, Sijbrands E, Hofman A, Uitterlinden A, Franco
O, Kiefte-de Jong J: Vitamin D status and metabolic syndrome in the elderly: the Rotterdam Study. Eur J Endocrinol 2015, 172(3):327.
53.
Hossein-Nezhad A, Khoshniat Nikoo M, Maghbooli Z, Karimi F, Mirzaei K, Hosseini A,
Larijani B: Relationship between serum vitamin D concentration and metabolic syndrome among Iranian
adults population. Daru 2009, 17(Suppl 1):1-5.
54.
Neyestani TR, Hajifaraji M, Omidvar N, Eshraghian MR, Shariatzadeh N, Kalayi A, Khalaji
N, Haidari H, Zowghi T, Nikooyeh B: High prevalence of vitamin D deficiency in school-age children in Tehran, 2008: a
red alert. Public Health Nutr 2012, 15(02):324-330.
55.
Salekzamani S, Neyestani TR, Alavi-Majd H, Houshiarrad A, Kalayi A, Shariatzadeh N,
Gharavi Aa: Is vitamin D status a determining factor for metabolic syndrome? A case-control study. Diabetes Metab Syndr Obes 2010, 4:205-212.
56.
Hovsepian S, Amini M, Aminorroaya A, Amini P, Iraj B: Prevalence of vitamin D deficiency among adult population of Isfahan City, Iran. J Health Popul Nutr 2011, 29(2):149.
57.
Ardawi M-S, Sibiany A, Bakhsh T, Qari M, Maimani A: High prevalence of vitamin D deficiency among healthy Saudi Arabian men: relationship
to bone mineral density, parathyroid hormone, bone turnover markers, and lifestyle
factors. Osteoporos Int 2012, 23(2):675-686.
58.
Baroncelli GI, Bereket A, El Kholy M, Audi L, Cesur Y, Ozkan B, Rashad M, Fernández-Cancio
M, Weisman Y, Saggese G: Rickets in the Middle East: role of environment and genetic predisposition. J Clin Endocrinol Metab 2008, 93(5):1743-1750.
59.
Wang TJ, Zhang F, Richards JB, Kestenbaum B, Van Meurs JB, Berry D, Kiel DP, Streeten
EA, Ohlsson C, Koller DL: Common genetic determinants of vitamin D insufficiency: a genome-wide association
study. Lancet 2010, 376(9736):180-188.
60.
Khader YS, Batieha A, Jaddou H, Batieha Z, El-Khateeb M, Ajlouni K: Relationship between 25-hydroxyvitamin D and metabolic syndrome among Jordanian adults. Nutr Res Pract 2011, 5(2):132-139.
61.
Reis JP, von Mühlen D, Miller ER: Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome
among US adults. Eur J Endocrinol 2008, 159(1):41-48.
62.
Khosravi-Boroujeni H, Ahmed F, Sarrafzadegan N: Is the Association between Vitamin D and Metabolic Syndrome Independent of Other Micronutrients? Int J Vitam Nutr Res 2016, 1(1):1-16.